Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Pulmonary Embolism and EGFR[original query] |
---|
Mutations in NSCLC and their link with lung cancer-associated thrombosis: a case-control study. Thrombosis research 2014 Jan 133 (1): 48-51. Corrales-Rodriguez Luis, Soulières Denis, Weng Xiaoduan, Tehfe Mustapha, Florescu Marie, Blais Norma |
A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancer. Oncotarget 2016 Oct . Levy Antonin, Bardet Etienne, Lacas Benjamin, Pignon Jean-Pierre, Adam Julien, Lacroix Ludovic, Artignan Xavier, Verrelle Pierre, Le Péchoux Céci |
[Clinical Predictive Factors associated with First Line EGFR-TKI Efficacy ?in Advanced NSCLC Patients with EGFR Mutations]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2019 Feb 22 (2): 99-104. Chen Minjiang, Xu Yan, Zhao Jing, Zhong Wei, Wang Mengzh |
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis. Current medical research and opinion 2019 10 36 (3): 477-482. Cho Byoung Chul, Kim Dong-Wan, Park Keunchil, Lee Jong-Seok, Yoo Seung Soo, Kang Jin Hyoung, Lee Sung Yong, Kim Cheol Hyeon, Jang Seung Hun, Kim Young-Chul, Yoon Hyoung-Kyu, Han Ji-Youn, Kim Sang- |
Risk of thromboembolism in patients with ALK- and EGFR-mutant lung cancer: A cohort study. Journal of thrombosis and haemostasis : JTH 2020 12 19 (3): 822-829. Roopkumar Joanna, Poudel Shyam K, Gervaso Lorenzo, Reddy Chandana A, Velcheti Vamsidhar, Pennell Nathan A, McCrae Keith R, Khorana Alok |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: